Suchergebnisse - "Fullerton, Aaron"

PubPharm (7)

1

A BCMA/CD16A bispecific innate cell engager for the treatment of multiple myeloma

enthalten in: Leukemia | 2022

von Kakiuchi-Kiyota, S. | Ross, T. | Wallweber, H. | +27

2

General Principles for the Validation of Proarrhythmia Risk Prediction Models : An Extension of the CiPA In Silico Strategy

enthalten in: Clinical pharmacology and therapeutics | 2020

von Li, Z. | Mirams, G. | Yoshinaga, T. | +39

3

Trovafloxacin-induced replication stress sensitizes HepG2 cells to tumor necrosis factor-alpha-induced cytotoxicity mediated by extracellular signal-regulated kinase and ataxia telangiectasia and Rad3-related

enthalten in: Toxicology | 2015

von Beggs, K. | Maiuri, A. | Fullerton, A. | +4

4

Molecular mechanisms of hepatocellular apoptosis induced by trovafloxacin-tumor necrosis factor-alpha interaction

enthalten in: Toxicological sciences : an official journal of the Society of Toxicology | 2014

von Beggs, K. | Fullerton, A. | Miyakawa, K. | +2

5

Pretreatment with TCDD exacerbates liver injury from Concanavalin A : critical role for NK cells

enthalten in: Toxicological sciences : an official journal of the Society of Toxicology | 2013

von Fullerton, A. | Roth, R. | Ganey, P.

6

2,3,7,8-TCDD enhances the sensitivity of mice to concanavalin A immune-mediated liver injury

enthalten in: Toxicology and applied pharmacology | 2013

von Fullerton, A. | Roth, R. | Ganey, P.

7

Natural killer cells mediate severe liver injury in a murine model of halothane hepatitis

enthalten in: Toxicological sciences : an official journal of the Society of Toxicology | 2011

von Dugan, C. | Fullerton, A. | Roth, R. | +1

1
[1]